|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/4188 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3272754 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17182338.8 |
| Date of filing the European patent application | 2013-01-25 | |
| (97) | Date of publication of the European application | 2018-01-24 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261591001 P | 2012-01-26 | US | |
| 201261669902 P | 2012-07-10 | US | |
| PCT/CN2012/0867 | 2012-12-14 | WO |
| (72) |
FURET, Pascal, CH
GUAGNANO, Vito, CH
HOLZER, Philipp, CH
KALLEN, Joerg, CH
LIAO, Lv, CN
MAH, Robert, CH
MAO, Liang, CH
MASUYA, Keiichi, CH
SCHLAPBACH, Achim, CH
STUTZ, Stefan, CH
VAUPEL, Andrea, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | IMIDAZOPYRROLIDINONE COMPOUNDS |
| IMIDAZOPYRROLIDINONE COMPOUNDS |